Investing.com - Equillium (NASDAQ: EQ) reported second quarter EPS of $0.010, $0.16 better than the analyst estimate of $-0.150. Revenue for the quarter came in at $13.9M versus the consensus estimate of $6.33M.
Equillium's stock price closed at $0.71. It is down -53.530% in the last 3 months and down -11.350% in the last 12 months.
Equillium saw 0 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Equillium's stock price’s past reactions to earnings here.
According to InvestingPro, Equillium's Financial Health score is "fair performance".
Check out Equillium's recent earnings performance, and Equillium's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Should you invest $2,000 in EQ right now?
Before you buy stock in EQ, consider this: ProPicks AI are 6 easy-to-follow model portfolios created by Investing.com for building wealth by identifying winning stocks and letting them run. Over 150,000 paying members trust ProPicks to find new stocks to buy – driven by AI. The ProPicks AI algorithm has just identified the best stocks for investors to buy now. The stocks that made the cut could produce enormous returns in the coming years. Is EQ one of them?
Reveal Undervalued Stocks Now